Description

CJC-1295 Overview

CJC-1295 (with DAC) is a synthetic analog of growth hormone-releasing hormone (GHRH), studied for its role in supporting sustained growth hormone release. The DAC (Drug Affinity Complex) modification extends its half-life, allowing for prolonged activity within research models.

It is commonly explored in studies involving hormonal regulation, recovery, and performance optimization.

Key Research Focus

• Sustained growth hormone release and regulation
• Support for recovery and body composition
• Long-acting hormonal signaling and performance

Mechanism of Action

CJC-1295 binds to GHRH receptors in the pituitary gland, stimulating the release of growth hormone. The DAC modification allows the peptide to remain active for extended periods, making it a focus in research involving sustained hormonal signaling and long-term performance effects.